Leading the pharmaceutical industry in sustainability

Around the world, we continuously work to reduce our environmental impact, improve health and wellbeing of our communities, and lead the fight against antimicrobial resistance.

Read more

Meeting highest standards

Read more
Fill 1 Created with Sketch.
Media release

Centrient Pharmaceuticals boosting statins API manufacturing capacity

Centrient Pharmaceuticals (“Centrient”), the global leader in sustainable antibiotics, next-generation statins and anti-fungals, announced today to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed, the company will double its statins production capacity. This will enable Centrient to meet growing demand for its sustainably manufactured Atorvastatin and Rosuvastatin Active Pharmaceutical Ingredients (APIs).

read more
Story

Saving lives in COVID-19 times: Mission Oxygen in India

read more
Media release

Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms

read more

Here's why we think you should come work with us:

  • Make an impact
  • Build a winning career
  • Become part of a global network
Read more
2200

employees around the globe

150

years of innovation

75

years of antibiotics

14

locations

america

Close to customers everywhere

Our manufacturing sites and sales offices around the globe are the cornerstones of our customer and supplier relationships, providing on-the-ground support and ensuring security of supply

read more
europe